Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Devoogdt

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Molecules (Basel, Switzerland)|April 23, 2020
Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET ImagingJessica Bridoux, Sara Neyt, Pieterjan Debie, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2025
VyPAL2 peptide asparaginyl ligase enables versatile workflows for radiolabeling single-domain antibody-based theranosticsSofie Declercq, Wei Min Chen, Abbas El Sahili, et al.
Immunobiology|December 3, 2014
Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigmFang Zheng, Nick Devoogdt, Amanda Sparkes, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2024
Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogelsJulie Heremans, Robin Maximilian Awad, Jessica Bridoux, et al.
Cancers|June 26, 2019
Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic AgentKatrijn Broos, Quentin Lecocq, Catarina Xavier, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2019
Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative BioconjugationGeert-Jan Graulus, Duy Tien Ta, Huong Tran, et al.
European Journal of Immunology|June 27, 2023
A few good reasons to use nanobodies for cancer treatmentNeema Ahishakiye Jumapili, Maida Zivalj, Romina Mora Barthelmess, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2011
Nanobody-coupled microbubbles as novel molecular tracerSophie Hernot, Sunil Unnikrishnan, Zhongmin Du, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 29, 2021
Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for <sup>68</sup>Ga-labelingHenri Baudhuin, Pieter-Jan Van Bockstal, Thomas De Beer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint BlockadeQuentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Molecules (Basel, Switzerland)|April 23, 2020
Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET ImagingJessica Bridoux, Sara Neyt, Pieterjan Debie, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2025
VyPAL2 peptide asparaginyl ligase enables versatile workflows for radiolabeling single-domain antibody-based theranosticsSofie Declercq, Wei Min Chen, Abbas El Sahili, et al.
Immunobiology|December 3, 2014
Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigmFang Zheng, Nick Devoogdt, Amanda Sparkes, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2024
Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogelsJulie Heremans, Robin Maximilian Awad, Jessica Bridoux, et al.
Cancers|June 26, 2019
Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic AgentKatrijn Broos, Quentin Lecocq, Catarina Xavier, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2019
Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative BioconjugationGeert-Jan Graulus, Duy Tien Ta, Huong Tran, et al.
European Journal of Immunology|June 27, 2023
A few good reasons to use nanobodies for cancer treatmentNeema Ahishakiye Jumapili, Maida Zivalj, Romina Mora Barthelmess, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2011
Nanobody-coupled microbubbles as novel molecular tracerSophie Hernot, Sunil Unnikrishnan, Zhongmin Du, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 29, 2021
Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for <sup>68</sup>Ga-labelingHenri Baudhuin, Pieter-Jan Van Bockstal, Thomas De Beer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint BlockadeQuentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, et al.
Pageof 16